Phase
Condition
Hypercholesterolemia
Myocardial Ischemia
Coronary Artery Disease
Treatment
Myocardial Perfusion Imaging Study
AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults ≥18 able to give informed consent.
Clinical indication for PET-MPI as determined by the subject's treating physician
Exclusion
Exclusion Criteria:
Any clinical contraindication for pharmacologic stress testing per ASNC/SNMMI/ACC myocardial perfusion imaging guidelines when stress perfusion imaging is required clinically.
Inability or unwilling to give informed consent
Pregnant subjects
Study Design
Study Description
Connect with a study center
Doral Imaging Institute, LLC dba CIRA
Miami, Florida 33165
United StatesActive - Recruiting
Adler Institute for Advanced Imaging
Jenkintown, Pennsylvania 19046
United StatesCompleted
UPMC
Pittsburgh, Pennsylvania 15213
United StatesCompleted
Molecular Imaging Technologies
El Paso, Texas 79912
United StatesCompleted

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.